To learn about our educational Webinars visit us at www.RedHookCapital.com or for the Webinar the 21st via GoToWebinar: http://alturl.com/hvx2b or https://attendee.gotowebinar.com/register/5671687043462755328
CB Insights FundingFlash count down show 66 deals that closed with $405.6 million funding showing Jan. 2013 off to a good start.
BIOTECH DEALS THAT CLOSED (PRE-JP MORGAN CONFERENCE):
Avex is a stealth company developing medical devices for improving arterial, venous and lymphatic circulation.
Actinium Pharmaceuticals engages in the research, development, and commercialization of the alpha emitting isotopes bismuth 213 and actinium 225 for fighting cancer and other cellular diseases. actiniumpharmaceuticals.com
Calithera Biosciences, formerly Protein Activation Therapeutics, develops therapeutic approaches to the treatment of cancer by using small molecules to activate, rather than inhibit, enzymes. calithera.com
Innovaci is a stealth technology enabled consumer products company. Innovaci is Innovaci was formed to take ideas in the health and wellness sector from concept to product. The company is developing a smart personalized air-enhancement device for the hospitality industry. testing prototypes of its first product.
Linkage Biosciences is a molecular diagnostics company developing products that will dramatically improve and expedite complex genetic testing. linkagebiosciences.com
Symbiosis Health develops a platform that allows patients on High Deductible Health Plans to save money on medical expenses and optimize deductible spend. The company’s platform provides pre-negotiated prices for the medical procedures employees need. symbiosishealth.com
For more details contact me at jdm.networking@gmail.com on Investor Events and deals that closed!
Happy Investing and Networking,
JD Morris
To learn about our educational Webinars visit us at www.RedHookCapital.com or for the Webinar the 21st via GoToWebinar: http://alturl.com/hvx2b or https://attendee.gotowebinar.com/register/5671687043462755328
Monteris Medical Inc., a Plymouth, Minn.-based developer of MRI-guided, laser-based brain cancer treatments, has raised $7.8 million in new VC funding. Business Development Bank of Canada led the round, and was joined by SWMF Life Science Fund. http://www.monteris.com
Tryton Medical Inc., a Durham, N.C.-based developer of stents designed to treat bifurcation lesions, has raised $24 million in new VC funding. PTV Sciences led the round, and was joined by fellow return backers RiverVest Venture Partners, Spray Venture Partners, and the 3×5 Special Opportunity Fund. http://www.trytonmedical.com
Marinus Pharmaceuticals Inc., a Branford, Conn.-based developer of neurosteroids for CNS disorders, has raised $21 million in Series C funding. Backers include Domain Associates, RusnanoMedInvest, Canaan Partners, Sofinnova Ventures and Foundation Medical Partners. http://www.marinuspharma.com
Solstice Biologics LLC, a San Francisco biotech startup focused on targeting and delivery of nucleic acid therapeutics, has raised $18 million in Series A funding. VenBio led the round, and was joined by Aeris Capital.